Latest From Biotech Now

Ten Years After 9/11 and the Anthrax Attacks

Bacillus anthracis

Yesterday, the U.S. Senate Committee on Homeland Security and Governmental Affairs held a hearing entitled, “Ten Years After 9/11 and the Anthrax Attacks: Protecting Against Biological Threats”. As stated by Chairman Lieberman in his opening remarks, the goal of the hearing was to examine whether the federal government “has developed the tools we need to respond effectively to a bioterror attack or naturally-occurring pandemic disease, to develop and disseminate vaccines and antibiotics, and to respond Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

On Food Day, Basic Human Needs Should be Top Priority

Ab-Basu_home

By Ab Basu, Executive Vice President (Acting), Food and Agriculture, Biotechnology Industry Organization Here in the United States, Food Day (October 24, 2011) can be a day to recognize the achievements of American agriculture. We can – and should – celebrate our nation’s farmers, who consistently provide a safe, reliable and affordable food supply. Even during a current weak economy, agriculture is one sector that is thriving. In America, agriculture is a tremendous success story. Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Company Snapshot: Immune Design

immunedesign

In the third installment of the Investor Forum Company Snapshots, hear from Immune Design Corp. The CEO of the company, Dr. Carlos Paya, will be presenting next week at the 10th Annual BIO Investor Forum on Tuesday afternoon. Company Snapshot What are the short-term and long-term priorities for your company? Short term: focus on validating in patients a product from each of our two novel technologies.  We will be conducting testing of : 1) An Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Confessions of a Cancer-Free Cancer Patient

Sandra Dennis

By Sandra Dennis, Deputy General Counsel for Healthcare, the Biotechnology Industry Organization October is breast cancer awareness month. As a dear friend said to me recently — it’s a whole month? She also despises the whole pink ribbon thing. I didn’t dare mention to her that there’s a breast cancer stamp. While it could suggest a lack of empathy, she was treated for breast cancer several years ago, so she speaks from the perspective of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Medical Innovation at Risk

Scientists

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investments towards Europe and Asia. The report, Vital Signs: The Threat to Investment in U.S. Medical Innovation and the Imperative of FDA Reform, strongly indicates that America’s medical innovation economy is in grave danger of losing its primary source of funding, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,